CD90 Antikörper (FITC)

Produktnummer ABIN780367

Dieser Maus Monoklonal Antikörper detektiert spezifisch CD90 in FACS. Es zeigt Reaktivität gegenüber Proben von Human, Schwein, Pferd und Non-Human Primate. Es wurde in 10+ Publikationen zitiert.

Kurzübersicht für CD90 Antikörper (FITC) (ABIN780367)

Target: CD90 (THY1)

Reaktivität: Human, Schwein, Pferd, Non-Human Primate

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser CD90 Antikörper ist konjugiert mit FITC

Applikation: Flow Cytometry (FACS)

Klon: 5E10

Produktdetails anti-CD90 Antikörper (FITC)

Verwendungszweck: Anti-Hu CD90 FITC

Keine Kreuzreaktivität: Hund

Kreuzreaktivität (Details): Human, Non-Human Primates, Porcine, Equine (Horse)

Produktmerkmale: The mouse monoclonal antibody 5E10 recognizes CD90/Thy-1, a GPI-anchored cell surface glycoprotein expressed predominantly on thymocytes, hematopoietic stem cells and neurons.

Aufreinigung: Purified antibody is conjugated with fluorescein isothiocyanate (FITC) under optimum conditions and unconjugated antibody and free fluorochrome are removed by size-exclusion chromatography.

Immunogen: HEL erythroleukemia cells

Isotyp: IgG1, kappa

Anwendungsinformationen

Applikationshinweise: Flow cytometry: The reagent is designed for analysis of human blood cells using 4 μL reagent / 100 μL of whole blood or 10⁶ cells in a suspension. The content of a vial (0.4 ml) is sufficient for 100 tests.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Do not freeze,Protect from prolonged exposure to light

Lagerung: 4 °C

Informationen zur Lagerung: Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.

Referenzen für anti-CD90 Antikörper (FITC) (ABIN780367)

Emadedin, Labibzadeh, Fazeli, Mohseni, Hosseini, Moghadasali, Mardpour, Azimian, Goodarzi, Ghorbani Liastani, Mirazimi Bafghi, Baghaban Eslaminejad, Aghdami: "Percutaneous Autologous Bone Marrow-Derived Mesenchymal Stromal Cell Implantation Is Safe for Reconstruction of Human Lower Limb Long Bone Atrophic Nonunion." in: Cell journal, Vol. 19, Issue 1, pp. 159-165, (2017) (PubMed).

Labibzadeh, Emadedin, Fazeli, Mohseni, Hosseini, Moghadasali, Mardpour, Azimian, Ghorbani Liastani, Mirazimi Bafghi, Baghaban Eslaminejad, Aghdami: "Mesenchymal Stromal Cells Implantation in Combination with Platelet Lysate Product Is Safe for Reconstruction of Human Long Bone Nonunion." in: Cell journal, Vol. 18, Issue 3, pp. 302-309, (2016) (PubMed).

Barale, Dentelli, Togliatto, Trombetta, Olgasi, Scozzari, Toppino, Morino, Brizzi: "High glucose via NOX-dependent ROS generation and AKT activity promotes adipose-derived stem cell de-differentiation." in: Stem cells and development, (2012) (PubMed).

Hoppstädter, Diesel, Zarbock, Breinig, Monz, Koch, Meyerhans, Gortner, Lehr, Huwer, Kiemer: "Differential cell reaction upon Toll-like receptor 4 and 9 activation in human alveolar and lung interstitial macrophages." in: Respiratory research, Vol. 11, pp. 124, (2010) (PubMed).

Kroeze, Jurgens, Doulabi, van Milligen, Scheper, Gibbs: "Chemokine-mediated migration of skin-derived stem cells: predominant role for CCL5/RANTES." in: The Journal of investigative dermatology, Vol. 129, Issue 6, pp. 1569-81, (2009) (PubMed).

Carlsten, Björkström, Norell, Bryceson, van Hall, Baumann, Hanson, Schedvins, Kiessling, Ljunggren, Malmberg: "DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells." in: Cancer research, Vol. 67, Issue 3, pp. 1317-25, (2007) (PubMed).

Chin-Yee, Keeney, Stewart, Belch, Bence-Buckler, Couban, Howson-Jan, Rubinger, Stewart, Sutherland, Paragamian, Bhatia, Foley: "Optimising parameters for peripheral blood leukapheresis after r-metHuG-CSF (filgrastim) and r-metHuSCF (ancestim) in patients with multiple myeloma: a temporal analysis of CD34(+) absolute counts and subsets." in: Bone marrow transplantation, Vol. 30, Issue 12, pp. 851-60, (2002) (PubMed).

Seiffert, Brossart, Cant, Cella, Colonna, Brugger, Kanz, Ullrich, Bühring: "Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells." in: Blood, Vol. 97, Issue 9, pp. 2741-9, (2001) (PubMed).

Ito, Inaba, Inaba, Toki, Sogo, Iguchi, Adachi, Yamaguchi, Amakawa, Valladeau, Saeland, Fukuhara, Ikehara: "A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 163, Issue 3, pp. 1409-19, (1999) (PubMed).

St Louis, Woodcock, Franzoso, Blair, Carlson, Murillo, Wells, Williams, Smoot, Kaushal, Grimes, Harlan, Chute, June, Siebenlist, Lee, Fransozo: "Evidence for distinct intracellular signaling pathways in CD34+ progenitor to dendritic cell differentiation from a human cell line model." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 162, Issue 6, pp. 3237-48, (1999) (PubMed).

Details zu CD90

Target: CD90 (THY1)

Andere Bezeichnung: CD90

Hintergrund: Thy-1 cell surface antigen,CD90 (Thy-1) is an 18-35 kDa GPI-anchored plasma membrane glycoprotein expressed in many cell types, such as in hematopoietic cells and neurons, connective tissues, various fibroblast and stromal cell lines, tumor endothelial cell lines and other. It is involved in T cell activation, cellular adhesion, proliferation and migration, neurite outgrowth, wound healing, apoptosis, and fibrosis. CD90 participates in multiple signaling cascades and its effects are tissue- and cell type-specific. It often functions as an important regulator of cell-cell and cell-matrix interactions.,Thy-1

Gen-ID: 7070

UniProt: P04216

Pathways: Cell-Cell Junction Organization